학술논문

The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance
Document Type
Journal
Source
FRONTIERS IN IMMUNOLOGY; DEC 9 2022, 13 p983181 22p.
Subject
Language
English
ISSN
16643224